2019
DOI: 10.1007/978-3-030-33246-4_25
|View full text |Cite
|
Sign up to set email alerts
|

Process-Based Quality Management in Care: Adding a Quality Perspective to Pathway Modelling

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
2
1
1
1

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 36 publications
0
2
0
Order By: Relevance
“… 2 , 38 , 39 However, these indicators usually cannot be used to infer quality of care unless there is an a priori establishment of a cause-and-effect relationship between the process and the outcome of interest, 2 which is mostly warranted for the indicators in our study because we considered only those based on evidence and could be further appraised by the level of evidence of each one. Another reason for the overrepresentation might be the international favoring of process indicators to translate evidence into practice 38 , 39 and the utilization of recent methods of quality improvement, such as clinical pathways 40 or other process-oriented approaches. 41 …”
Section: Discussionmentioning
confidence: 99%
“… 2 , 38 , 39 However, these indicators usually cannot be used to infer quality of care unless there is an a priori establishment of a cause-and-effect relationship between the process and the outcome of interest, 2 which is mostly warranted for the indicators in our study because we considered only those based on evidence and could be further appraised by the level of evidence of each one. Another reason for the overrepresentation might be the international favoring of process indicators to translate evidence into practice 38 , 39 and the utilization of recent methods of quality improvement, such as clinical pathways 40 or other process-oriented approaches. 41 …”
Section: Discussionmentioning
confidence: 99%
“…For each process, the input sheets were filled in by the domain experts of the working group and based on the current evidence as identified with the evidence review process. This information was then used to detail the single processes if necessary and to develop a process model of the patient pathway template using a BPMN.io modeling environment adapted to patient pathway specific requirements [23], [28] as presented in Figure 4. Quality indicators were included as blue circles and adaptation notes as comments to the corresponding pathway concepts.…”
Section: Demonstration -The Oncology Use Casementioning
confidence: 99%